Catalyzing breakthroughs

Cambrian is developing new therapies to extend healthy lifespan, bringing proven scientific and organizational expertise to exceptional research teams worldwide.


The synthesis of inspiration and rigor

We are passionate about combining exciting breakthroughs in biomedicine with a data-driven approach to constructing a pipeline of therapies.


Building medicines of the future

We partner with exceptional scientists to bring a new class of medicines to patients in need, built around understanding the deep science of the “Nine Hallmarks of Aging” with the potential to both treat and prevent today’s deadliest diseases.


Bringing medicine truly into the 21st century

James Peyer, CEO at Cambrian

James Peyer

Chief Executive Officer and Co-Founder

Christian Angermayer, co-founder at Cambrian

Christian Angermayer

Chairman and Co-Founder

Juliette Han, Cambrian's COO

Juliette Han

Chief Operating Officer

Tauhid Ali, EVP at Cambrian

Tauhid Ali

EVP, Translational and Clinical Science

Dennis Yamashita, EVP Chemistry at Cambrian

Dennis Yamashita

EVP, Chemistry

Georg Terstappen, Drug discovery at Cambrian

Georg C. Terstappen

EVP, Drug Discovery